PREDICTION # 1: “Exposure Enforcement” Against Stem Cell Clinics Is About To Get More Personal…
Two years ago, a list of stem cell clinics, (along with their associated practitioners) offering “unproven”, “unapproved” cell-based...
PIONEERS OF HOPE: Doug Oliver's Interview with U.S. Senator Susan Collins
Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with...
PIONEERS OF HOPE: Doug Oliver's Interview with Harry Reid
Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with...
PIONEERS OF HOPE: Doug Oliver's Interview with Dr. Kapil Bharti, Ph.D., Principal Investigator f
“We are not giving up, until the point that we are confident that I can take these cells and put them in my daughter’s eye or my...
PIONEERS OF HOPE: Doug Oliver's Interview of Senator Bill Frist, Former Senate Majority Leader &
Doug Oliver: On behalf of the Regenerative Outcomes Foundation, Senator Frist, a genuine thank you. This is a real privilege to talk with...
PIONEERS OF HOPE: Doug Oliver's Interview of Dr. Francis Collins, Director of NIH, for the Regen
Doug recently had the honor of interviewing Francis Collins, Director of the National Institutes of Health, for the World Stem Cell...
Doug Oliver and the Regenerative Outcomes Foundation on the 21st Century Cures Act
Doug Oliver and the Regenerative Outcomes Foundation serve both regenerative medicine patients seeking healing, and the providers that help
FDA, Patients, and Providers: A Brand New “Relation-shift.”
I’m very positive about the future role of the FDA in ensuring that stem cell and related therapies are safe and effective. And, because...
What About Treatment #2?
I am always challenged and intellectually stimulated when I feel as though I’ve identified a pattern, practice, or even consequence of...
An Ambassador In Your Corner
Throughout the week of August 7th, I have visits in DC with top policymakers and regulators, politicians, stem cell industry leaders, resear
